Olaparib as treatment for platinum‐sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis
- DOI
- 10.1002/cncr.35707
- Published
- 2025-01-15
- Container
- Cancer
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/cncr.35707,
title = {Olaparib as treatment for platinum‐sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis},
author = {Ying L. Liu and Cara A. Mathews and Fiona Simpkins and Karen A. Cadoo and Diane Provencher and Colleen C. McCormick and Adam C. ElNaggar and Alon D. Altman and Lucy Gilbert and Destin Black and Nashwa Kabil and Rosie N. Taylor and Alan Barnicle and Jiefen Y. Munley and Carol Aghajanian},
year = {2025},
journal = {Cancer},
doi = {10.1002/cncr.35707},
url = {https://doi.org/10.1002/cncr.35707}
}RIS
TY - JOUR TI - Olaparib as treatment for platinum‐sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis AU - Ying L. Liu AU - Cara A. Mathews AU - Fiona Simpkins AU - Karen A. Cadoo AU - Diane Provencher AU - Colleen C. McCormick AU - Adam C. ElNaggar AU - Alon D. Altman AU - Lucy Gilbert AU - Destin Black AU - Nashwa Kabil AU - Rosie N. Taylor AU - Alan Barnicle AU - Jiefen Y. Munley AU - Carol Aghajanian PY - 2025 JO - Cancer DO - 10.1002/cncr.35707 UR - https://doi.org/10.1002/cncr.35707 ER -
APA
Liu, Y. L., Mathews, C. A., Simpkins, F., Cadoo, K. A., Provencher, D., McCormick, C. C., ElNaggar, A. C., Altman, A. D., Gilbert, L., Black, D., Kabil, N., Taylor, R. N., Barnicle, A., Munley, J. Y., & Aghajanian, C. (2025). Olaparib as treatment for platinum‐sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis. Cancer. https://doi.org/10.1002/cncr.35707
Source records
- crossref · retrieved 2026-09-27T00:38:22.800Z